Spectranetics Acquires AngioScore for $230,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0048a641-07a9-47b8-83eb-1a8448252d40
Date
5/27/2014
Company Name
AngioScore
Mailing Address
5055 Brandin Court Fremont, CA 94538 USA
Company Description
AngioScore, Inc. develops, makes and sells leading edge tools for endovascular therapy. Our first product, the AngioSculpt Scoring Balloon Catheter, has received CE mark approval and is available for sale in Europe. Clinical trials are underway in the United States.
Website
http://www.angioscore.com
Transaction Type
M&A
Transaction Amount
$230,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The Spectranetics Corporation SPNC -8.25% today announced that it has entered into a definitive merger agreement under which Spectranetics will acquire AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons for $230 million in up-front consideration, along with additional contingent commercial and regulatory milestone payments.